Roche Holding AG (ROG.VX)


Swiss - Swiss Delayed Price. Currency in CHF
242.90+0.90 (+0.37%)
At close: 11:30 AM EDT
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Open242.00
Prev Close242.00
Bid242.70 x 111700
Ask242.00 x 265600
Day's Range241.90 - 243.70
52wk Range229.90 - 281.40
1y Target EstN/A
Market Cap206.99B
P/E Ratio (ttm)22.01
BetaN/A
Volume1,162,837
Avg Vol (3m)237,048
Dividend & YieldN/A (N/A)
Earnings DateN/A
  • Financial Times5 hours ago

    [$$] Bristol-Myers Squibb misses mark with cancer drug

    Merck and Bristol-Myers Squibb have spent most of the past two years in a two-horse race to develop and sell immunotherapies, a new class of cancer drug that turns the body into a weapon against the disease.  ...

  • MarketWatchyesterday

    European stocks book a loss as rate-hike signals intensify

    European stocks on Monday finish in negative territory, kicking off the week lower as rising expectations the U.S. Federal Reserve will lift interest rates later this year poke the air out of a recent ...

  • MarketWatchyesterday

    FDA grants Roche Zika test emergency authorization

    Swiss drug maker Roche Holding AG said on Monday the U.S. Food and Drug Administration has issued an "emergency use authorization" for the its Zika test in another step to tackle the virus that ...